<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02734329</url>
  </required_header>
  <id_info>
    <org_study_id>RenJiH-2016006</org_study_id>
    <nct_id>NCT02734329</nct_id>
  </id_info>
  <brief_title>Zero Ischemia Laparoscopic Radio Frequency/Microwave Ablation Assisted Enucleation of Renal Cell Carcinoma With T1 Stage</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>RenJi Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Xinhua Hospital, Shanghai Jiao Tong University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shanghai Changzheng Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Changhai Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shanghai 6th People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Fudan University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>RenJi Hospital</source>
  <brief_summary>
    <textblock>
      Zero ischemia laparoscopic radio frequency ablation assisted tumor enucleation has been
      proved to enable tumor excision with relatively better renal function preservation comparing
      with conventional laparoscopic partial nephrectomy for T1a renal cell carcinoma (RCC) in a
      randomized clinical trial in single center. The investigators want to explore this technique
      to T1 RCC patients in randomized clinical trial in multiple centers.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2016</start_date>
  <primary_completion_date type="Anticipated">September 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>the change in glomerular ﬁltration rate (GFR) of the affected kidney</measure>
    <time_frame>Baseline and 30 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>changes of estimated GFR (eGFR)</measure>
    <time_frame>Baseline and 30 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>estimated blood loss</measure>
    <time_frame>during surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>rates of positive surgical margin</measure>
    <time_frame>postoperative，up to 2 weeks after surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>postoperative complications</measure>
    <time_frame>postoperative，up to 30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the rate of local recurrence</measure>
    <time_frame>through study completion, an average of 3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>operative time</measure>
    <time_frame>During surgery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital stay time</measure>
    <time_frame>The time from the surgery day to patient discharge, up to 2 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>progression-free survival rate</measure>
    <time_frame>through study completion, an average of 3 years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Kidney Neoplasms</condition>
  <arm_group>
    <arm_group_label>Zero Ischemia group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Radiofrequency ablation(RFA) /Microwave ablation(MVA) will be performed for 1 to 4 cycles each depending on tumor size and depth. The tumor then will be laparoscopic enucleation without hilar clamping in most cases.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Renal hilum will be accurately isolated and then the artery only will be clamped during surgery.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>conventional laparoscopic partial nephrectomy</intervention_name>
    <description>renal artery will be clamped during surgery.</description>
    <arm_group_label>Conventional group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>zero ischemia laparoscopic RFA/MVA assisted tumor enucleation (TE)</intervention_name>
    <arm_group_label>Zero Ischemia group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with sporadic, unilateral, newly diagnosed T1 presumed renal cell carcinoma

          -  patients scheduled for laparoscopic nephron sparing surgery

          -  patients agreeable to participate in this long-term follow-up study

        Exclusion Criteria:

          -  patients' aged &gt;80 years

          -  patients with other renal diseases,(including kidney stone, glomerular nephritis,
             etc.) which might affect the renal function of the operative kidney

          -  patients not able to tolerate the laparoscopic procedure

          -  patients with previous renal surgery or history of any inﬂammatory conditions of the
             operative kidney

          -  patients with the renal tumor involving urinary collecting system
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>jiwei huang, M.D.</last_name>
    <phone>862168383776</phone>
    <email>jiweihuang@outlook.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University</name>
      <address>
        <city>Shanghai</city>
        <zip>200127</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>jiwei huang, M.D</last_name>
      <phone>86-21-68383716</phone>
      <email>jiweihuang@outlook.com</email>
    </contact>
    <investigator>
      <last_name>Yiran Huang, M.D</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>May 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 29, 2016</study_first_submitted>
  <study_first_submitted_qc>April 5, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 12, 2016</study_first_posted>
  <last_update_submitted>May 1, 2016</last_update_submitted>
  <last_update_submitted_qc>May 1, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 3, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>RenJi Hospital</investigator_affiliation>
    <investigator_full_name>Yiran Huang</investigator_full_name>
    <investigator_title>Director of Urology</investigator_title>
  </responsible_party>
  <keyword>Nephron sparing surgery</keyword>
  <keyword>Zero ischemia</keyword>
  <keyword>Warm ischemia</keyword>
  <keyword>Laparoscopic</keyword>
  <keyword>Radiofrequency ablation</keyword>
  <keyword>Microwave ablation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

